Elevance Health Inc. ($ELV) Stock Forecast: Up 5.2% Today

What is Elevance Health Inc.?

Elevance Health (ELV) is a managed healthcare company listed on the NYSE. The stock had a strong bullish movement today.

Why is Elevance Health Inc. going up?

ELV stock is up 5.2% on Apr 23, 2026 17:26

• Adjustments in price targets were made by Barclays and Deutsche Bank, with Barclays raising it to $408 and Deutsche Bank to $363.
• The positive sentiment from analysts following these adjustments likely contributed to the bullish movement.
• CMS issued a threat to block enrollment in Medicare drug plans for Elevance Health, leading to a temporary drop in the stock price.
• Earnings for Q1 2026 surpassed expectations, with an EPS of $12.58 and revenue of $49.49 billion, potentially further fueling the bullish movement.
• Market sentiment may have been influenced by the upcoming Q1 earnings announcement from HCA Healthcare, with analysts monitoring for potential impacts on the healthcare sector.

ELV Price Chart

ELV Technical Analysis

ELV News

Barclays Adjusts Price Target on Elevance Health to $408 From $393, Maintains Overweight Rating

Barclays has increased its price target for Elevance Health (ELV) to $408 from $393, while reiterating an Overweight rating on the stock. This adjustment reflects an updated outlook from the investment bank regarding the managed healthcare company. The article also notes other analyst adjustments for Elevance Health on the same day.

https://www.marketscreener.com/news/barclays-adjusts-price-target-on-elevance-health-to-408-from-393-maintains-overweight-rating-ce7f59dedb8af02c

Deutsche Bank Lifts Price Target on Elevance Health to $363 From $332, Keeps Hold Rating

Deutsche Bank has increased its price target for Elevance Health (ELV) to $363 from $332, while maintaining a Hold rating on the stock. This adjustment reflects an updated outlook by the bank's analysts on the healthcare company's valuation. The news follows other analyst adjustments for Elevance Health, including Evercore ISI and Baird, signaling active analyst coverage around the stock.

https://www.marketscreener.com/news/deutsche-bank-lifts-price-target-on-elevance-health-to-363-from-332-keeps-hold-rating-ce7f59ded98efe21

Elevance Health drops as CMS threatens to block enrollment in Medicare drug plans

This article is severely truncated and provides only a title and a very brief mention of content. It states that Elevance Health's stock dropped due to a threat from CMS to block enrollment in Medicare drug plans.

http://www.msn.com/en-us/health/other/elevance-health-drops-as-cms-threatens-to-block-enrollment-in-medicare-drug-plans/ar-AA1XnYFX?gemSnapshotKey=GM84E996BB-snapshot-1&uxmode=ruby&apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1&bundles=feat-es2020-t

Elevance Health, Inc. 2026 Q1 - Results - Earnings Call Presentation (NYSE:ELV) 2026-04-22

Elevance Health, Inc. published its Q1 2026 earnings call presentation, reporting an EPS of $12.58, beating estimates by $1.77, and revenue of $49.49 billion, surpassing expectations by $1.59 billion (1.49% Y/Y). The article highlights the financial results and notes that the content is from the company's official slide deck.

https://seekingalpha.com/article/4893156-elevance-health-inc-2026-q1-results-earnings-call-presentation

What To Expect From HCA Healthcare’s (HCA) Q1 Earnings

HCA Healthcare is set to announce its Q1 earnings this Friday. The market expects a 4.1% year-on-year revenue growth, a slowdown from the previous year. Analysts have largely maintained their estimates, even though the company has frequently missed Wall Street's revenue forecasts in the past two years.

https://www.tradingview.com/news/stockstory:51a13fde3094b:0-what-to-expect-from-hca-healthcare-s-hca-q1-earnings/

Trending Today

AMC Entertainment Holdings Inc. Class A ($AMC) Stock Forecast: Down 5.1% Today

Palantir Technologies Inc ($PLTR) Stock Forecast: Down 7.0% Today

Super Micro Computer Inc ($SMCI) Stock Forecast: Down 8.3% Today

lululemon athletica inc. ($LULU) Stock Forecast: Down 11.3% Today

International Business Machines Corporation ($IBM) Stock Forecast: Down 7.5% Today

Huntington Bancshares Incorporated ($HBAN) Stock Forecast: Down 1.7% Today

Revvity ($RVTY) Stock Forecast: Down 10.0% Today

West Pharmaceutical Services Inc. ($WST) Stock Forecast: Up 14.1% Today

NXP Semiconductors N.V. ($NXPI) Stock Forecast: Up 6.4% Today

Norfolk Southern Corporation ($NSC) Stock Forecast: Up 6.6% Today

Elevance Health Inc. Price History

10.02.2026 - ELV Stock was up 5.1%

• ELV stock experienced a strong bullish movement today.
• Pinkerton Wealth LLC significantly increased its stake in Elevance Health, indicating confidence in the company's market position and growth potential, which likely contributed to the positive market sentiment.
• The reaffirmation of financial guidance by Centene Corp, a company specializing in health insurance programs, could have also positively influenced ELV's stock as it reflects stability and growth in the healthcare sector.
• The reduction in stake by the Swiss National Bank might have initially raised concerns, but the overall market sentiment seems to have been buoyed by the increased confidence shown by Pinkerton Wealth LLC and the positive industry outlook.

24.01.2026 - ELV Stock was down 5.2%

• The bearish movement in ELV stock could be attributed to profit-taking by investors after a recent bullish run or concerns about the company's growth prospects.
• The commitment of Elevance Health Foundation to funding food as medicine programs may have diverted investor attention away from ELV, impacting its stock performance negatively.
• Investors may be cautious about ELV's position in the market following news of competitors like Alignment Healthcare reporting membership gains and positive earnings growth.
• The broader market sentiment influenced by news of Humana's weaker earnings outlook and regulatory risks may have also contributed to the bearish trend in ELV stock.

03.02.2026 - ELV Stock was down 6.9%

• Today's downward trend in Elevance Health's stock (ELV) can be attributed to various factors:
• Uncertainty arising among investors due to the recent leadership changes and business consolidation.
• Investors viewing the increased regulatory focus on Elevance Health's Medicare Advantage plans as a potential risk factor.
• The positive news of the company raising its quarterly dividend and having a consensus price target above the current trading price may be overshadowed by ongoing regulatory actions and operational adjustments, contributing to the bearish market movement.

03.02.2026 - ELV Stock was down 6.4%

• The bearish movement in Elevance Health's stock today can be attributed to the threat of Medicare Advantage sanctions by CMS due to noncompliance with data submission requirements, which poses financial and reputational risks for the company.
• The positive news of increased investments by Harvest Portfolios Group Inc. and the South Dakota Investment Council may not have been enough to offset the concerns raised by the CMS sanctions, leading to a decline in investor confidence.
• The launch of a national pilot program to provide free diapers by Elevance Health's subsidiary, Elevance Health, could be seen as a positive social initiative but might not have directly impacted the stock movement significantly.
• Overall, the market sentiment towards Elevance Health seems to be influenced more by regulatory challenges and compliance issues rather than positive investment signals, leading to the bearish movement in the stock today.

27.00.2026 - ELV Stock was down 12.4%

• The bearish movement in ELV's stock can be attributed to the proposed flat rates for Medicare Advantage plans by the government, impacting major health insurers.
• Recent decisions by health insurers to adjust Medicare Advantage benefits and underwhelming Q4 performance reports have contributed to negative sentiment in the sector.
• Institutional investors have shown varying stances on ELV, with some reducing their stake while others increasing their position.
• The regulatory announcement regarding Medicare payment rate increases for 2027 has put pressure on healthcare companies reliant on Medicare Advantage plans, leading to a bearish trend in ELV's stock price.

27.00.2026 - ELV Stock was down 14.2%

• Elevance Health (ELV) experienced a strong bearish movement likely due to the broader sector-wide selloff following proposed changes in Medicare Advantage payment rates for 2027.
• The reduction in Medicare Advantage benefits by other companies, in response to disappointing reimbursement rates, further added to the negative sentiment surrounding healthcare stocks, including ELV.
• A reduction in stake by an institutional investor in Elevance Health could have also contributed to the downward pressure on the stock, signaling decreased institutional confidence in the company amidst regulatory uncertainty and market volatility.
• The upcoming earnings report of another company, and its recent poor financial performance leading to a new 52-week low, might have influenced investor sentiment towards riskier assets like ELV, contributing to the bearish movement.

28.00.2026 - ELV Stock was up 5.4%

• Elevance Health (ELV) saw a strong bullish movement following a positive reaction to surpassing profit expectations for Q4 2025.
• Despite a mix of results with profits exceeding expectations but revenues falling short investor confidence surged as the company focuses on affordability and platform enhancements.
• Analysts and investors found reassurance in the company's ability to outperform profit expectations and maintain a positive earnings per share outlook for 2026 amidst revenue growth challenges and margin pressures.
• The market shift may have been influenced by general sentiment towards the healthcare and insurance sectors, weighing concerns about margin risks and membership attrition against the company's profit beat and earnings forecast.

28.00.2026 - ELV Stock was up 5.1%

• ELV stock saw an upward trend driven by investors' favorable response to the company exceeding profit expectations in the fourth quarter of 2025.
• The strong performance in earnings per share, which outperformed analyst predictions, likely contributed to the optimistic market sentiment.
• Despite falling short of revenue targets, the emphasis on affordability and the earnings per share guidance of at least $25.50 for 2026 may have reassured investors about the company's future trajectory.
• Positive analyst evaluations and market outlooks appeared to have boosted investor confidence in ELV, influencing the bullish movement in the market.

23.03.2026 - ELV Stock was up 5.2%

• Adjustments in price targets were made by Barclays and Deutsche Bank, with Barclays raising it to $408 and Deutsche Bank to $363.
• The positive sentiment from analysts following these adjustments likely contributed to the bullish movement.
• CMS issued a threat to block enrollment in Medicare drug plans for Elevance Health, leading to a temporary drop in the stock price.
• Earnings for Q1 2026 surpassed expectations, with an EPS of $12.58 and revenue of $49.49 billion, potentially further fueling the bullish movement.
• Market sentiment may have been influenced by the upcoming Q1 earnings announcement from HCA Healthcare, with analysts monitoring for potential impacts on the healthcare sector.

27.01.2026 - ELV Stock was down 5.5%

• Speculations arose relating to investor concerns prompted by Close Asset Management Ltd's substantial reduction in ELV shares, potentially influencing the bearish market trend.
• The stock's reaffirmed 2026 earnings outlook might not have resonated positively with investors, resulting in a lack of favorable sentiment towards the company.
• Despite Elevance Health's emphasis on responsible AI integration and financial openness, negative market response to the management reshuffle announcements may indicate investor hesitancy.
• The focus on an educational seminar collaboration between Amlan International and Elanco could have diverted attention from Elevance Health, negatively affecting its stock performance as investors turned towards other industry players.

02.02.2026 - ELV Stock was down 4.9%

• The bearish movement in Elevance Health's stock today is linked to CMS imposing sanctions on the company, suspending Medicare enrollment for alleged noncompliance with risk adjustment data submission requirements.
• Despite surpassing quarterly EPS estimates and increasing its dividend, the adverse impact of CMS sanctions appears to overshadow the positive financial performance.
• The contrasting actions of institutional investors, with one increasing its stake significantly while another reducing its holdings, may have contributed to the uncertainty surrounding the stock.
• Elevance Health's efforts to collaborate with CMS and address compliance issues are acknowledged, but market sentiment seems cautious due to impending sanctions impacting the company's Medicare Advantage plans.

12.01.2026 - ELV Stock was up 4.2%

• ELV stock showed a significant bullish movement recently, potentially influenced by various factors:
• Wealthfront Advisers LLC notably increased its stake in ELV, suggesting optimism regarding the company's future prospects and financial performance.
• Although Zacks Research lowered its EPS forecast, ELV surpassed earnings expectations in the last quarter, raised its dividend, likely boosting investor confidence.
• Analysts' "Moderate Buy" rating and an average price target of $390.55 indicate a positive sentiment towards ELV, potentially contributing to the recent stock movement.
• The company's ability to maintain robust performance despite challenges from a shrinking customer base demonstrates resilience and growth potential, appealing to investors seeking opportunities in a competitive market.